These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24509748)

  • 1. Drug pipeline 4Q13.
    DeFrancesco L
    Nat Biotechnol; 2014 Feb; 32(2):125. PubMed ID: 24509748
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the drought over for pharming?
    Kaiser J
    Science; 2008 Apr; 320(5875):473-5. PubMed ID: 18436771
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug pipeline: Q311.
    Peng W
    Nat Biotechnol; 2011 Oct; 29(10):859. PubMed ID: 21997619
    [No Abstract]   [Full Text] [Related]  

  • 4. What ails the FDA?
    Gorelick KJ
    N Engl J Med; 2005 Jun; 352(24):2553-4. PubMed ID: 15958814
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 6. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 8. The EMEA guideline on first-in-human clinical trials and its impact on pharmaceutical development.
    Milton MN; Horvath CJ
    Toxicol Pathol; 2009 Apr; 37(3):363-71. PubMed ID: 19246571
    [No Abstract]   [Full Text] [Related]  

  • 9. Fresh from the biotech pipeline--2013.
    Kling J
    Nat Biotechnol; 2014 Feb; 32(2):121-4. PubMed ID: 24509747
    [No Abstract]   [Full Text] [Related]  

  • 10. Issues in bringing new drugs to the market.
    Tracey WR
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172
    [No Abstract]   [Full Text] [Related]  

  • 11. Striking the right balance.
    Nat Rev Drug Discov; 2006 Nov; 5(11):879. PubMed ID: 17117516
    [No Abstract]   [Full Text] [Related]  

  • 12. Sending pharma better signals.
    Avorn J
    Science; 2005 Jul; 309(5735):669. PubMed ID: 16051753
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs that made headlines in 2016.
    Keener AB
    Nat Med; 2016 Dec; 22(12):1377-1379. PubMed ID: 27923025
    [No Abstract]   [Full Text] [Related]  

  • 16. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage?
    Roman A
    Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA drug information that never reaches clinicians.
    Messerli FH; Bangalore S
    N Engl J Med; 2010 Feb; 362(6):562; author reply 563. PubMed ID: 20175300
    [No Abstract]   [Full Text] [Related]  

  • 18. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 19. The United States Food and Drug Administration and the end of antibiotics.
    Shlaes DM; Moellering RC
    Clin Infect Dis; 2002 Feb; 34(3):420-2. PubMed ID: 11774094
    [No Abstract]   [Full Text] [Related]  

  • 20. To market, to market. The nuts and bolts of prescription drug approval.
    Peterson AM
    Adv Nurse Pract; 2001 Apr; 9(4):87-90. PubMed ID: 12420443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.